21 news items
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
ABBV
AZN
LLY
14 Jun 24
the primary endpoint of improvement in motor function, which was assessed by change in the North Star Ambulatory Assessment ("NSAA") at one year
Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry
ABBV
11 Jun 24
evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When assessing AbbVie against its top 4 peers using
Analyst Scoreboard: 6 Ratings For AbbVie
ABBV
5 Jun 24
qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative
RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis
ABBV
4 Jun 24
.16 A Study to Assess Change in Disease Activity
AbbVie's Options Frenzy: What You Need to Know
ABBV
3 Jun 24
trading surrounding AbbVie, we move to examine the company in more detail. This includes an assessment of its current market status and performance
g48ee
ABBV
BMY
17 May 24
to assess antipsychotic treatment efficacy.
“When we compare the two products, we believe emraclidine differentiates by its
i2qizqq4cle0wqdv
ABBV
17 May 24
qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative
bezz6sfj47xx25qbb1ooznydrvhtwwj80t
ABBV
17 May 24
include an economic analysis and oral presentation that assessed inflammation biomarkers
- Additional
p1kn08 o0je1o2u1hpvlt9q38phipiadny5keb0xg2saz1nh8k9moc
ABBV
17 May 24
(STELARA®) in Crohn's disease include an economic analysis and oral presentation that assessed inflammation
tixousbtxle81s
ABBV
29 Apr 24
of the company.
Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform
o09y7fifyroc3tifzuf9pz4gxmfk200u7 5z1emzb5n9zfdr0mbg7q3g
ABBV
REGN
SNY
25 Apr 24
dermatitis.
AbbVie said the study is the first head-to-head trial in atopic dermatitis assessing
whtqj6pig5qivz08intucgs8xehypjxf5naqlq
ABBV
25 Apr 24
respectively, p<0.0001)].1The EASI is a clinically validated measure used to assess the severity and extent of atopic dermatitis, while the WP
osidssn9uj3p5ebao2emeafc17jt97d7 v9
ABBV
25 Apr 24
)].1
The EASI is a clinically validated measure used to assess the severity
mpdc9whs9iqh9c808j15q9krm2behig3hlgwig
ABBV
18 Apr 24
. In addition, the study assessed the safety and tolerability of upadacitinib in these patients. The second period will evaluate the safety
d928nupmn0 71fs2l7chwq1s0xt0rpw63s93qfd19ubozayz9tmtlvzrgcm
ABBV
18 Apr 24
, the study assessed the safety and tolerability of upadacitinib in these patients. The second period will evaluate the safety and efficacy of continuing
op5l2uacowc3i18tw7tsaks4pit76498rcs39wl827xvfq
ABBV
12 Apr 24
, double-blind, placebo-controlled trial assessing the safety, tolerability, and efficacy of atogepant 60 mg once daily (QD) compared with placebo
51qq9hzroae348ygwyv8ije8mx8m 6adn36m5
ABBV
5 Apr 24
over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options
1rqwvl2l7esib 1hhdpz
ABBV
4 Apr 24
the recent three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading
vbkn2n2lobfu80vuphwly9qdce3z0h51pq2056fx3v4vy1vts3z
ABBV
26 Mar 24
ratio, AbbVie can be assessed by comparing it to its top 4 peers, resulting in the following observations:
In terms of the debt
nw6jdguh1epy4p33pjt8n7ycm670
ABBV
22 Mar 24
was progression-free survival (PFS) by investigator assessment and key secondary endpoints included objective response rate (ORR) and overall survival (OS